Review
Open access
Sep 2026
HALP score in solid tumors: Prognostic value, heterogeneity, and translational considerations
Highlights • HALP integrates anemia, nutrition, immunity, and systemic inflammation.• Low HALP is generally linked to poorer outcomes across solid tumors.• Cutoff heterogeneity limits threshold transferability and clinical use.• Prospective validation is required before routine implementation.
Zian Jin, Chang-Hong Dong, K. Hui et al.
· Translational Oncology · 0 citations